Lifestyle trends and health tips
Proposed Medicare fee schedule changes may incentivize doctors to provide more support for smoking cessation, increasing reimbursements for counseling services.
Drug shortages in the U.S. have surged to 227, while GSK halts development of its chronic cough treatment after disappointing trial results.
The recent U.S. policy on testosterone screenings highlights disparities in access to hormone therapy, notably affecting LGBTQ+ individuals.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
MDCalc is enhancing trust in clinical decision-making by implementing a new quality-rating system for its calculators, impacting how physicians use these tools.
MAHA's recent initiatives signal a pivotal shift in the dialogue around mental health care, emphasizing deprescribing while sidelining concrete solutions.
The FTC's settlement with CVS Caremark aims to save Americans up to $8.5 billion on insulin by overhauling price manipulation and rebate practices.
Sales under the U.S. drug discount program reached $100 billion in 2025, driven largely by high-cost medications.
Cyclospora infections are at a record high, with Michigan officials pointing to lettuce as a potential source amid an outbreak across multiple states.
HCA Healthcare projects a significant profit drop due to a surge in uninsured patients after subsidy changes under the Affordable Care Act.
Health workers in the DRC protest unpaid wages as Ebola cases rise, highlighting the urgent need for coordinated global health responses.
This week's biotech podcast discusses rising health insurance costs and the whistleblower case against an insurer, alongside industry developments.
A significant cyclospora outbreak in Michigan has exceeded 1,000 cases, prompting investigations across several states as health officials seek the source.
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent research from OpenEvidence questions the effectiveness of large language models in health technology applications, presenting new insights into AI capabilities.
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
A recent analysis of GLP-1 telehealth platforms reveals significant variation in service quality, highlighting the need for more regulated standards.
Chris Deacon’s tireless efforts led to a $100 million settlement with Horizon Blue Cross Blue Shield, though her contributions remain overshadowed by political figures.
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.